GRAIL, Inc. Common Stock
Limited financial coverage for GRALV.
Not enough data to compute a meaningful composite — typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available stats still render below.
Price Chart
About the company
GRAIL, LLC is a biotechnology firm dedicated to pioneering solutions for the early identification of cancer. The company offers Galleri, a multi-cancer early detection screening test designed for healthy individuals aged 50 and above who show no symptoms. Additionally, it provides DAC, a diagnostic assistance tool aimed at accelerating the diagnostic process for patients with a clinical suspicion of cancer.
- CEO
- Robert P. Ragusa
- HQ
- Menlo Park, CA, US
Get TickerSpark's AI analysis on GRALV
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- 52W High
- $23.36
- 52W Low
- $12.51
- 50D MA
- $15.94
- 200D MA
- $15.94
- Beta
- 0.00
- RSI (14)
- 53
- Avg Volume
- 2.37M
No earnings-call transcripts are available for GRALV yet.
- Free Float
- 0.0%
- Shares Outstanding
- 31.10M
- Float Shares
- 0
Held by 4 ETFs
Biggest fund positions in GRALV by dollar value.
Our GRALV coverage
Recent articles, reports, and earnings notes.
No research on GRALV yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate GRALV report →